Search Results - Seock-Ah Im

Refine Results
  1. 1

    BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs? by Peter Dubsky, Christian Jackisch, Seock-Ah Im, Kelly K. Hunt, Chien-Feng Li, Sheila Unger, Shani Paluch-Shimon

    Published in npj Breast Cancer (2024-09-01)
    Get full text
    Article


  2. 2

    HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless o... by Jeongmin Seo, Jiwon Koh, Dae-Won Lee, Jinyong Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im

    Published in Breast Cancer Research (2023-12-01)
    Get full text
    Article


  3. 3

    Development of a Novel Orthotopic Gastric Cancer Mouse Model by Wonyoung Kang, Leigh Maher, Michael Michaud, Seong-Woo Bae, Seongyeong Kim, Hye Seung Lee, Seock-Ah Im, Han-Kwang Yang, Charles Lee

    Published in Biological Procedures Online (2021-01-01)
    Get full text
    Article


  4. 4

    Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. by Younak Choi, Do-Youn Oh, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  5. 5

    Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer:... by Johannes Ettl, Seock-Ah Im, Jungsil Ro, Norikazu Masuda, Marco Colleoni, Patrick Schnell, Eustratios Bananis, Dongrui R. Lu, Massimo Cristofanilli, Hope S. Rugo, Richard S. Finn

    Published in Breast Cancer Research (2020-03-01)
    Get full text
    Article


  6. 6

    Cyclin dependent kinase 9 inhibitor induces transcription-replication conflicts and DNA damage accumulation in breast cancer by Minyoung Lee, Kyung-Hun Lee, Ahrum Min, So Hyeon Kim, Sujin Ham, Hae Min Hwang, Youlim Noh, Yu-Jin Kim, Dae-Won Lee, Jiwon Koh, Seock-Ah Im

    Published in Cancer Cell International (2025-07-01)
    Get full text
    Article


  7. 7

    The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer by Ji Eun Choi, Jae Seok Lee, Min-Sun Jin, Ilias P. Nikas, Kwangsoo Kim, Sunah Yang, Soo Young Park, Jiwon Koh, Sohyeon Yang, Seock-Ah Im, Han Suk Ryu

    Published in Breast Cancer Research (2023-11-01)
    Get full text
    Article


  8. 8

    Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER... by Soohyeon Lee, Kyunghee Park, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Woong-Yang Park, Seock-Ah Im, Yeon Hee Park

    Published in Breast (2022-04-01)
    Get full text
    Article


  9. 9

    Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations by Jinyong Kim, Kyeonghun Jeong, Hyeji Jun, Kwangsoo Kim, Jeong Mo Bae, Myung Geun Song, Hanbaek Yi, Songyi Park, Go-un Woo, Dae-Won Lee, Tae-Yong Kim, Kyung-Hun Lee, Seock-Ah Im

    Published in Human Genomics (2023-01-01)
    Get full text
    Article


  10. 10

    TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperabl... by Peter Schmid, Mafalda Oliveira, Joyce O’Shaughnessy, Massimo Cristofanilli, Stephanie L. Graff, Seock-Ah Im, Sherene Loi, Shigehira Saji, Shusen Wang, David W. Cescon, Tina Hovey, Agata Nawrot, Karson Tse, Petra Vukovic, Giuseppe Curigliano

    Published in Therapeutic Advances in Medical Oncology (2025-04-01)
    Get full text
    Article


  11. 11

    TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgica... by Aditya Bardia, Lajos Pusztai, Kathy Albain, Eva Maria Ciruelos, Seock-Ah Im, Dawn Hershman, Kevin Kalinsky, Claudine Isaacs, Delphine Loirat, Laura Testa, Eriko Tokunaga, Jiong Wu, Hannah Dry, William Barlow, Robert Kozarski, Micah Maxwell, Nadia Harbeck, Priyanka Sharma

    Published in Therapeutic Advances in Medical Oncology (2024-04-01)
    Get full text
    Article


  12. 12

    Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer. by Hye Rim Ha, Do-Youn Oh, Tae-Yong Kim, KyoungBun Lee, Kyubo Kim, Kyung-Hun Lee, Sae-Won Han, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Yung-Jue Bang

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  13. 13

    Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural e... by Soon-Chan Kim, Ga-Hye Kim, Jae-Hyeon Park, Kyung-Hun Lee, Jiwon Koh, Tae-Yong Kim, Dae-Won Lee, Yu-Jin Kim, Seongyeong Kim, Song-Yi Park, Ahrum Min, Young-Kyoung Shin, Seock-Ah Im, Ja-Lok Ku

    Published in Breast Cancer Research (2025-05-01)
    Get full text
    Article


  14. 14

    797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer by Changhee Park, Yeon Hee Park, Seock-Ah Im, Jeehyun Kim, Koung Jin Suh, Se Hyun Kim, Min Hwan Kim, Jae Ho Jeong, Kyoung Eun Lee, Hee-Jun Kim, Eun Kyung Cho, In Sil Choi, Seung-Jae Noh, Inkyung Shin, Dae-Yeon Cho

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  15. 15

    Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of th... by Rebecca Dent, Javier Cortés, Yeon Hee Park, Eva Muñoz-Couselo, Sung-Bae Kim, Joohyuk Sohn, Seock-Ah Im, Esther Holgado, Theodoros Foukakis, Sherko Kümmel, Jennifer Yearley, Anran Wang, Michael Nebozhyn, Lingkang Huang, Razvan Cristescu, Petar Jelinic, Vassiliki Karantza, Peter Schmid

    Published in Breast Cancer Research (2025-03-01)
    Get full text
    Article


  16. 16

    The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer by Jangsoon Lee, Kumiko Kida, Jiwon Koh, Huey Liu, Ganiraju C. Manyam, Young Jin Gi, Dileep R. Rampa, Asha S. Multani, Jing Wang, Gitanjali Jayachandran, Dae-Won Lee, James M. Reuben, Aysegul Sahin, Lei Huo, Debu Tripathy, Seock-Ah Im, Naoto T. Ueno

    Get full text
    Article


  17. 17

    MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer by Cheng Hyun Lee, Soo Young Park, Jae Seok Lee, Da Sol Kim, Ha Yeon Kim, Min Ji Song, Seock-Ah Im, Kyung-Hun Lee, Dae-Won Lee, Ilias P. Nikas, Ji Won Koh, So Hyeon Yang, Hyebin Lee, Han Suk Ryu

    Published in Breast Cancer Research (2025-07-01)
    Get full text
    Article


  18. 18

    Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial by Yongjoo Kim, Chan-Woo Yeom, Hyun Jeong Lee, Jeong-Hyun Kim, Kwang-Min Lee, Tae-Yong Kim, Han-Byoel Lee, Hoon Kim, Seock-Ah Im, Kyung-Hun Lee, Miso Kim, Wonsik Han, Hyeong-Gon Moon, David Spiegel, Bong-Jin Hahm, Kyung-Lak Son

    Published in npj Breast Cancer (2024-07-01)
    Get full text
    Article


  19. 19

    Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy by Javier Cortes, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Keun Seok Lee, Peter Schmid, Kenji Tamura, Laura Testa, Shoichiro Ohtani, Nadia Harbeck, Sherene Loi, Roberto Salgado, Vassiliki Karantza, Jaime Mejia, Razvan Cristescu, Andrey Loboda, Michael Nebozhyn, Petar Jelinic, Lingkang Huang, Eric P. Winer

    Published in npj Breast Cancer (2025-10-01)
    Get full text
    Article


  20. 20

    Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine. by Gerald Goh, Ramona Schmid, Kelly Guiver, Wichit Arpornwirat, Imjai Chitapanarux, Vinod Ganju, Seock-Ah Im, Sung-Bae Kim, Arunee Dechaphunkul, Jedzada Maneechavakajorn, Neil Spector, Thomas Yau, Mehdi Afrit, Slim Ben Ahmed, Stephen R Johnston, Neil Gibson, Martina Uttenreuther-Fischer, Javier Herrero, Charles Swanton

    Published in PLoS Medicine (2016-12-01)
    Get full text
    Article


Search Tools: